BIOT Annual CFO
-$1.47 M
0.00%
31 December 2021
Summary:
As of February 5, 2025, BIOT annual cash flow from operations is -$1.47 millionBIOT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIOT Quarterly CFO
-$143.60 K
-$3700.00-2.64%
30 September 2022
Summary:
As of February 5, 2025, BIOT quarterly cash flow from operations is -$143.60 thousand, with the most recent change of -$3700.00 (-2.64%) on September 30, 2022. Over the past year, it has increased by +$391.10 thousand (+73.14%).BIOT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIOT TTM CFO
-$696.80 K
+$391.10 K+35.95%
30 September 2022
Summary:
As of February 5, 2025, BIOT TTM cash flow from operations is -$696.80 thousand, with the most recent change of +$391.10 thousand (+35.95%) on September 30, 2022. Over the past year, it has increased by +$457.40 thousand (+39.63%).BIOT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIOT Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +73.1% | +39.6% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
BIOT Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -158.6% | +12.5% |
Biotech Acquisition Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$143.60 K(+2.6%) | -$696.80 K(-35.9%) |
| June 2022 | - | -$139.90 K(+36.8%) | -$1.09 M(+54.8%) |
| Mar 2022 | - | -$102.30 K(-67.1%) | -$702.80 K(-52.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$1.47 M | -$311.00 K(-41.8%) | -$1.47 M(+26.9%) |
| Sept 2021 | - | -$534.70 K(-318.1%) | -$1.15 M(+86.3%) |
| June 2021 | - | $245.20 K(-128.4%) | -$619.50 K(-28.4%) |
| Mar 2021 | - | -$864.70 K | -$864.70 K |
FAQ
- What is Biotech Acquisition annual cash flow from operations?
- What is the all time high annual CFO for Biotech Acquisition?
- What is Biotech Acquisition quarterly cash flow from operations?
- What is the all time high quarterly CFO for Biotech Acquisition?
- What is Biotech Acquisition quarterly CFO year-on-year change?
- What is Biotech Acquisition TTM cash flow from operations?
- What is the all time high TTM CFO for Biotech Acquisition?
- What is Biotech Acquisition TTM CFO year-on-year change?
What is Biotech Acquisition annual cash flow from operations?
The current annual CFO of BIOT is -$1.47 M
What is the all time high annual CFO for Biotech Acquisition?
Biotech Acquisition all-time high annual cash flow from operations is -$1.47 M
What is Biotech Acquisition quarterly cash flow from operations?
The current quarterly CFO of BIOT is -$143.60 K
What is the all time high quarterly CFO for Biotech Acquisition?
Biotech Acquisition all-time high quarterly cash flow from operations is $245.20 K
What is Biotech Acquisition quarterly CFO year-on-year change?
Over the past year, BIOT quarterly cash flow from operations has changed by +$391.10 K (+73.14%)
What is Biotech Acquisition TTM cash flow from operations?
The current TTM CFO of BIOT is -$696.80 K
What is the all time high TTM CFO for Biotech Acquisition?
Biotech Acquisition all-time high TTM cash flow from operations is -$619.50 K
What is Biotech Acquisition TTM CFO year-on-year change?
Over the past year, BIOT TTM cash flow from operations has changed by +$457.40 K (+39.63%)